when is retatrutide going to be available Retatrutide: The New Triple-Agonist Weight Loss Treatment Retatrutide Dosing Guide for Researchers

Despite these promising developments, GLP-1 therapies remain relatively new

The bottom line Switching from a compounded glucagon-like peptide-1 (GLP-1) to a brand-name option may seem overwhelming

Insurance policies vary significantly between employers, states, and insurance carriers

It remains unclear if the benefits are from the drug itself or weight loss

Rapid weight loss can lead to dehydration and kidney injury, particularly in individuals with a history of kidney issues

Some small studies using gastric ultrasound and upper endoscopy have documented retained food particles in the stomachs of certain patients taking GLP-1 agonists after overnight fasting periods